Literature DB >> 6141917

Metabolism of procainamide to a hydroxylamine by rat and human hepatic microsomes.

J P Uetrecht, B J Sweetman, R L Woosley, J A Oates.   

Abstract

We have previously demonstrated that procainamide is oxidized to a reactive metabolite. We speculated that this reactive metabolite might be a hydroxylamine and further that it might be responsible for the syndrome of procainamide-induced lupus. We now report that procainamide is metabolized to a hydroxylamine by rat and human hepatic microsomes. The extent of this metabolic oxidation was quantitated by HPLC after conversion of the hydroxylamine to the more stable nitro derivative of procainamide. Formation of the hydroxylamine required NADPH, active microsomes, and oxygen and was inhibited by carbon monoxide, SKF 525-A, and cimetidine. Formation of the hydroxylamine was also studied as a function of time, microsomal protein concentration, and procainamide concentration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6141917

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  9 in total

Review 1.  Idiosyncratic drug reactions: possible role of reactive metabolites generated by leukocytes.

Authors:  J P Uetrecht
Journal:  Pharm Res       Date:  1989-04       Impact factor: 4.200

Review 2.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

3.  Metabolism of procainamide to the cytotoxic hydroxylamine by neutrophils activated in vitro.

Authors:  R L Rubin; J T Curnutte
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

4.  N-Hydroxylation of dapsone by multiple enzymes of cytochrome P450: implications for inhibition of haemotoxicity.

Authors:  H J Gill; M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

5.  Autoantibodies associated with lupus induced by diverse drugs target a similar epitope in the (H2A-H2B)-DNA complex.

Authors:  R L Rubin; S A Bell; R W Burlingame
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

7.  Metabolites of procainamide and practolol inhibit complement components C3 and C4.

Authors:  E Sim; L Stanley; E W Gill; A Jones
Journal:  Biochem J       Date:  1988-04-15       Impact factor: 3.857

Review 8.  Initiation of autoimmunity by a reactive metabolite of a lupus-inducing drug in the thymus.

Authors:  R L Rubin; A Kretz-Rommel
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

9.  Machine Learning for Predicting Risk of Drug-Induced Autoimmune Diseases by Structural Alerts and Daily Dose.

Authors:  Yue Wu; Jieqiang Zhu; Peter Fu; Weida Tong; Huixiao Hong; Minjun Chen
Journal:  Int J Environ Res Public Health       Date:  2021-07-03       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.